Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 52023PC0193

    Initiative summary:
    The revision of the general pharmaceutical legal framework, aims to ensure access to affordable medicines in the EU. It aims to foster innovation including in areas of unmet medical need (such as in antimicrobials) and to enhance security of supply while adapting to new scientific and technological developments and reducing regulatory burden where possible. Drawing lessons from the COVID-19 pandemic, it will support a future-proof and crisis-resistant pharmaceuticals system.
    EuroVoc thesaurus:
    tervishoiupoliitika; sildistamine; institutsioonide tegevus; turustusnorm; Euroopa Ravimiamet; tarbijateave; varustuskindlus; müügiluba; ravimiseadusandlus; ravim; rahvatervis
    • Documents:
      Ares(2021)2185074 (Inception impact assessment)
      Ares(2021)2390324 (Inception impact assessment)
      Ares(2022)977395 (Factual summary report of the public consultation)
      Leading service:
      Directorate-General for Health and Food Safety
      Planned adoption period:
      01/10/2022 - 31/12/2022
      Check the status of this initiative on the Better Regulation Portal
      • Consultation type:
        Stakeholder feedback
        Consultation duration (weeks):
        4
      • Consultation type:
        Public consultation
        Consultation duration (weeks):
        12
      • Consultation type:
        Stakeholder feedback
        Consultation duration (weeks):
        4
    • Documents:
      COM/2023/193 final (Proposal for a regulation)
      Staff working document
      Leading service:
      Directorate-General for Health and Food Safety
      • Consultation type:
        Stakeholder feedback
        Consultation duration (weeks):
        8